|
Interagency Task Force on Military and Veterans Mental Health (ITF)
|
Committee, Work group, Advisory group, or Task Force
|
ACL, OS, SAMHSA
|
NIMH
|
Executive Order 13625, Improving Access to Mental Health Services for Veterans, Service Members, and Military Families, was released on August 31, 2012, and directed the Departments of Defense (DoD), Veterans Affairs (VA), and Health and Human Services (HHS) to ensure that Veterans, Service Members, and their families have access to needed mental health services and support. The Executive Order also established the Interagency Task Force on Military and Veterans Mental Health (ITF) and directed it to provide an annual review of agency actions, to define specific goals and metrics to aid in measuring progress, and make additional recommendations as appropriate to the President to improve mental health and substance use disorder treatment services for Veterans, Service Members, and their families. The ITF, co-chaired by the DoD Assistant Secretary for Health Affairs, the VA Under Secretary for Health, and the HHS Administrator for the Substance Abuse and Mental Health Services Administration, tracks and reports progress in executing all activities resulting from recommendations made pursuant to the Executive Order.
|
|
Interagency Workgroup on Child Abuse and Neglect
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, CDC, IHS, SAMHSA
|
NICHD, CSR, NIAAA, NIDA, NIMH, NINDS, OD/DPCPSI/OBSSR
|
The Federal Interagency Workgroup on Child Abuse and Neglect meets to provide a forum through which staff from relevant federal agencies can communicate and exchange ideas concerning the prevention of child maltreatment and other related issues.
|
|
Interagency Workgroup on Technology to Facilitate Aging in Place
|
Research Initiative
|
ACL, CMS, FDA
|
NIA, NCI, NHLBI, NIBIB, NINDS, NINR
|
The purpose of this Trans-NIH/Inter-Agency group is to develop new platforms for everyday life technology that will enhance the common goals of multiple NIH institutes and other federal government agencies by improving the capability to rapidly conduct peer-reviewed technology research to facilitate aging in place, with a special emphasis on people from underrepresented groups. A platform is a group of technologies that are used as a base upon which other applications, processes or technologies are developed.
|
|
Interagency Working Group in the Glycosciences
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIGMS, NCI, NICHD, NIDCR, NIDDK
|
This group meets annually to identify synergies, discuss progress on the development of national standards for carbohydrates and exchanges information on the glycosciences being pursued at each agency
|
|
Interagency Working Group on Neuroscience
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIMH, NIA, NIDA, NINDS, NINR, OD/DPCPSI/OBSSR
|
By Executive Order, the White House Office of Science and Technology Policy established the Interagency Working Group on Neuroscience (IWGN) by action of the National Science and Technology Council. The purpose of the group is to foster collaboration across agencies and to coordinate federal investments in neuroscience research. The IWGN coordinates activities in neuroscience research across the Federal Government with a focus on the fundamental understanding of learning, brain development and plasticity, and brain health and recovery. The IWGN enhances federal efforts related to: improving our understanding of learning and cognition, and applying this understanding to improvements in education and other areas; improving our understanding of a variety of neurological conditions and injuries; and developing appropriate resources, tools, techniques, interventions, and therapies to assist in research, treatment, and recovery. The IWGN includes members from the Departments of Agriculture, Defense, Education, Energy, Health and Human Services, Homeland Security, Justice, and Veterans Affairs, as well as the Central Intelligence Agency, Environmental Protection Agency, National Aeronautics and Space Administration, the National Science Foundation, and the Office of the Director of National Intelligence.
|
|
Interagency Working Group on Open Science
|
Committee, Work group, Advisory group, or Task Force
|
ACL, AHRQ, CDC, FDA, OS
|
OD/OSP, OD/OER
|
On February 22, 2013, the Director of the White House Office of Science and Technology Policy (OSTP), Dr. John Holdren, issued a memorandum to all agency and department heads entitled, “Increasing Access to the Results of Federally Funded Scientific Research.” The memo directed federal agencies with more than $100 million in annual conduct of research and development to develop plans for increasing public access to peer-reviewed scientific publications and digital data resulting from federally funded research investments. Within HHS, six operating divisions and the Office of the Secretary meet this threshold. The HHS operating divisions have aligned their work through a common set of guiding principles and a framework around which they could develop implementation plans tailored to the needs of their research communities, taking into account their unique missions and legal authorities. OSTP also maintains federal-wide interagency working group.
|
|
International Cancer Control Partnership
|
Other
|
CDC
|
NCI
|
The National Cancer Institute and the Union for International Cancer Control convened global partners including CDC to cooperate in assisting countries to develop and implement quality cancer plans linked to Non-communicable Disease (NCD) control. This International Cancer Control Partnership, ICCP, believes that prioritizing cancer is critical to reaching the “25x25” goal. ICCP partners will assist countries by: creating a searchable database of current cancer control plans from around the globe; performing analysis of gaps and highlighting priority areas for inclusion in plans; training appropriate personnel to develop plans with targets and evaluation strategies; providing planners with relevant existing materials and tools; and offering technical assistance. ICCP partners will use their collective state, country and regional-level planning experience to guide plan development and implementation and will ensure planners utilize effective, evidence-based strategies to help meet the global NCD targets.
|
|
International Conference on Betel Quid and Areca Nut
|
Meeting/ Workshop
|
CDC
|
NCI, NIAID, NIDCR
|
This conference, held in April 2016, focused on understanding the impact of use of areca nut and betel quid, both with and without tobacco, and all its variants, addiction issues, and the associated cancers and other oral health issues, specifically cancers of the lip, mouth, tongue, pharynx, and esophagus.
|
|
International Consortium for Emergency Contraception Technical Advisory Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NICHD
|
International Consortium for Emergency Contraception (ICEC) Technical Advisory Group (TAG) brings together experienced scientists, researchers, and other thinkers not currently affiliated with an ICEC member organization. These experts provide technical advice and input to the Consortium and serve as individuals, not as representatives of their organization.
|
|
International Select Agent Review Group (ISARG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
OD/OSP, NIAID
|
Provides advice to NIAID on projects it intends to fund that involve the use of Select Agents and Toxins overseas.
|